Marit Austgulen Wick

Novel Diagnostics AS provides biomedical research and diagnostics development services. It sells and develops medical and diagnostic products and drives commercialization of research results. The firm also invests in securities; either in form of follow-up investments in companies already has invested in, or as part of other strategic investments. The company was founded on June 10, 2002 and is headquartered in Bergen, Norway.

ScreenCancer AS offers cancer screening and diagnostic program to the public. It provides a panel of screening tests for several major cancers such as colorectal, bladder, breast, prostate, skin, and lung. The company was founded by Christian Horn and Dagfinn Steinar Ogreid in 2007 and is headquartered in Sola, Norway.

Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway.

Sarsia Innovation AS invests in companies located in the northern part of Norway. Selected companies are from various sectors but they all are developing new concepts in their field. The fund is currently closed for new investments.

APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway.

Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway.

Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.

Balter Medical AS engages in the development and commercialization of biomedical technology. Its product assists healthcare professionals in diagnosing patients with Melanoma. The company was founded by Jakob Johan Stamnes and Knut Stamnes on December 13, 2000 and is headquartered in Bergen, Norway.

Sorbwater Technology AS operates as a fluid environmental services company which provides technology, processes and equipment. It develops IPR and utilization of the sorbfloc product in water treatment processes which until now has been considered impossible to treat with such cross linking hydrocolloids. The firm's products are biodegradable cross linking flocculent which they have made applicable for use in almost any waste water purification treatment process regardless of chemical composition of the water and the contamination. The company was founded by Atle Mundheim Ylikangas and Asbjorn Havsgard in 2007 and is headquartered in Bergen, Norway.

Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom.

WindSim AS develops and delivers software solutions and professional services for the wind energy industry worldwide. It offers WindSim, a wind farm design tool, which optimizes park layouts by identifying turbine locations with the highest wind speeds but with low turbulence to improve energy production while minimizing turbine load problems. The firm also offers product training, consulting, and technical support services. Its software is used by wind resource and energy assessors, meteorologists, and researchers at wind turbine manufacturers, project developers, government agencies, and academic institutions. The company was founded by Arne Reidar Gravdahl in 1993 and is headquartered in Tonsberg, Norway.

The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom.

Aquiloz AS develops, produces, and trades wind power forecasting and trading information system. The company was founded by Steinar Dragsnes, Gunnar Egidius, Jensen Trond Svanes, and Rune Reisegg Jacobsen on January 17, 2011 and is headquartered in Blomsterdalen, Norway.

Catalent Pharma Solutions Ltd. develops and markets drug delivery systems. The company is headquartered in Swindon, GB.

Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway.

Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway.

Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway.

Aenova Holding GmbH provides supplies to the pharmaceutical and healthcare industries. The firm develops, produces, and markets solid dosage products such as soft and hard capsules, tablets, film-coated tablets, and effervescent tablets. Its services include production, supply chain management, packaging, support and analytics. The company was founded in 2008 and is headquartered in Starnberg, Germany.

DCC Healthcare Ltd. supplies medical, surgical, and laboratory equipment and pharmaceuticals to the Irish healthcare sector. The company is headquartered in Stillorgan, Ireland.

Labrida AS provides novel device for maintenance of dental implants. The company was founded by Johan C. Wohlfahrt and Staale Petter Lyngstadaas in August 2012 and is headquartered in Oslo, Norway.

Epsis AS is a holding company that specializes in development and sales of its software Epsis TeamBox. Its product is a collaboration management software solution designed to facilitate meeting workflows and sharing of information, enabling "real-time" decision making in a collaborative environment. The company was founded on June 27, 2001 and is headquartered in Kokstad, Norway.

Gundersen & Moldestad AS is a Norwegian company that retails hardware and wholesales plumbing supplies, heating equipment, and hardware. The private company is based in Laksevåg, Norway.

AXIA Utvikling AS develops technologies that assist biotechnology companies in their research and development activities. It also participates, buys, and sells projects or businesses in information technology services. The firm develops technologies that assist biotechnology companies in their research and development activities. The company was founded on January 18, 2002 and is headquartered in Sarpsborg, Norway.

Kistefos AS engages in the provision of investment services. Its investment portfolio includes Norwegian and foreign companies within the segments offshore, shipping, financial services, telecommunications, and real estate, as well as financial investments. The company was founded by Christen Sveaas in 1889 and is headquartered in Oslo, Norway.